{"hands_on_practices": [{"introduction": "Viruses can be incredibly subtle in how they drive cancer, and it's a common misconception that they must always cause mutations in the host's DNA. This practice explores a more direct route: disabling a key cellular defender at the protein level. We'll examine a scenario involving Human Papillomavirus (HPV) where the tumor suppressor gene *TP53* appears perfectly normal, yet its crucial function is completely neutralized, a concept central to understanding HPV-driven cancers [@problem_id:2105292].", "problem": "A pathologist is analyzing a biopsy sample from a cervical tumor. Molecular analysis confirms the integration of DNA from Human Papillomavirus type 16 (HPV-16), a high-risk virus strongly associated with cervical cancer. To further characterize the tumor, the pathologist sequences the patient's *TP53* gene, which encodes the crucial tumor suppressor protein p53. Surprisingly, the sequencing results show that the *TP53* gene is wild-type, meaning it contains no mutations. This presents an apparent contradiction, as the oncogenic activity of HPV-16 is known to involve the disruption of the p53 pathway.\n\nWhich of the following statements provides the most accurate molecular explanation for how HPV-16 is contributing to cancer in this patient, despite the presence of a wild-type *TP53* gene?\n\nA. The HPV-16 E6 oncoprotein targets the p53 protein for degradation, thus eliminating its function at the protein level.\n\nB. The HPV-16 E7 oncoprotein binds to and mutates the *TP53* gene, leading to the production of a non-functional p53 protein.\n\nC. The presence of HPV-16 DNA is merely incidental; the cancer must have been caused by mutations in other tumor suppressor genes, such as the retinoblastoma (*RB1*) gene.\n\nD. The HPV-16 virus integrates into the promoter region of the *TP53* gene, blocking its transcription, which is why the protein is absent but the gene's coding sequence appears normal.\n\nE. The wild-type *TP53* gene is producing a stable p53 protein, but the HPV-16 E6 oncoprotein binds directly to the DNA-binding domain of p53, preventing it from activating its target genes.", "solution": "The key observation is that the patient’s TP53 gene is wild-type, yet the tumor exhibits HPV-16 integration, a hallmark of HPV-driven carcinogenesis. High-risk HPV-16 promotes oncogenesis primarily through the actions of its E6 and E7 oncoproteins at the protein level rather than by mutating host tumor suppressor genes.\n\nThe relevant molecular mechanisms are:\n- HPV-16 E6 binds p53 and recruits an E3 ubiquitin ligase (E6-AP/UBE3A), promoting ubiquitination and subsequent proteasomal degradation of p53. This leads to loss of p53 function despite an intact TP53 coding sequence. Thus, p53 pathway inactivation occurs post-translationally.\n- HPV-16 E7 binds the retinoblastoma protein (pRb), releasing E2F transcription factors and driving cell cycle progression. E7 does not mutate TP53.\n\nEvaluate the options:\n- Option A accurately states that E6 targets p53 for degradation, eliminating its function at the protein level despite a wild-type gene. This is the canonical mechanism in HPV-driven cancers.\n- Option B is incorrect: E7 does not mutate TP53, and HPV oncoproteins act at the protein level, not by introducing host gene mutations.\n- Option C is incorrect: the presence of HPV-16 is not incidental; HPV-16 E6/E7 are causally implicated, and TP53 need not be mutated when E6 degrades p53.\n- Option D is inaccurate as a general explanation: HPV integration sites are variable, and the hallmark effect is upregulation of E6/E7 due to disruption of viral E2, not consistent integration into the TP53 promoter. Moreover, TP53 coding sequence being normal does not imply promoter blockade, and the primary mechanism is protein degradation rather than transcriptional silencing of TP53.\n- Option E is less accurate: while E6 can interfere with p53-mediated transactivation via effects on cofactors, the defining and most accurate mechanism is ubiquitin-mediated degradation; furthermore, stating the p53 protein is stable contradicts E6’s principal activity.\n\nTherefore, the most accurate molecular explanation is Option A.", "answer": "$$\\boxed{A}$$", "id": "2105292"}, {"introduction": "In contrast to targeting existing proteins, some viruses contribute to cancer by physically disrupting the genetic blueprint itself. This exercise delves into the concept of 'insertional mutagenesis,' where the integration of viral DNA into a host chromosome can inactivate a critical gene. You will apply the classic 'two-hit hypothesis' of tumor suppressor inactivation to a scenario where a retroviral infection provides the final blow to a cell's growth control machinery [@problem_id:2105299].", "problem": "A research team is studying a line of human intestinal epithelial cells in culture. These cells are known to be heterozygous for a mutation in the Adenomatous Polyposis Coli (*APC*) gene, a critical tumor suppressor. The mutation in one allele results in a non-functional, truncated protein. The second allele remains wild-type, and the cells initially exhibit normal, controlled growth due to the sufficient function of the protein from this single wild-type allele. The *APC* protein is a key negative regulator of the Wnt signaling pathway; in its absence, the Wnt pathway becomes constitutively active, driving cell proliferation.\n\nTo investigate gene disruption events, the researchers infect the cell culture with an engineered retrovirus. This retrovirus is designed to integrate its proviral DNA into the host genome at random locations and does not carry any oncogenes of its own. After several weeks, the researchers observe distinct colonies of cells that have lost their normal growth control and are proliferating rapidly, forming multilayered foci characteristic of cellular transformation.\n\nUpon isolating and analyzing the DNA from several of these transformed colonies, they consistently find that the retrovirus has integrated into one of the exons of the remaining wild-type *APC* allele.\n\nWhich of the following statements provides the most accurate molecular explanation for the observed transformation of these cells?\n\nA. The retroviral integration event caused insertional mutagenesis that activated a nearby, unrelated proto-oncogene, and the observed integration into the *APC* gene is purely coincidental.\n\nB. Proteins expressed from the integrated retroviral genome directly interfere with the cell cycle checkpoints, causing uncontrolled proliferation independently of the *APC* gene.\n\nC. The integration of the retrovirus into the wild-type *APC* exon served as a \"second hit\", inactivating the only remaining functional copy of the tumor suppressor gene and leading to a complete loss of *APC* function.\n\nD. The truncated protein produced from the retrovirus-disrupted *APC* allele acts as a dominant-negative mutant, actively inhibiting any residual function from the protein product of the first mutated allele.\n\nE. The presence of foreign viral DNA triggered a profound inflammatory response within the cell that bypassed the normal regulatory function of the single remaining wild-type *APC* allele.", "solution": "We begin with the cellular genotype: the cells are $APC^{+/-}$, where one allele bears a truncating loss-of-function mutation and the other allele is wild-type. Because $APC$ is a tumor suppressor that negatively regulates Wnt signaling, the presence of one functional allele is initially sufficient to maintain controlled growth (haplosufficiency in this context).\n\nThe Wnt pathway is kept in check by $APC$, which promotes degradation of cytosolic $\\beta$-catenin. When $APC$ function is lost from both alleles, $\\beta$-catenin accumulates, translocates to the nucleus, and constitutively activates transcriptional programs that drive proliferation and transformation.\n\nThe engineered retrovirus integrates randomly and does not carry oncogenes. After infection and selection of transformed colonies, molecular analysis reveals that the provirus has integrated into an exon of the remaining wild-type $APC$ allele in multiple independent colonies. Integration into a coding exon is expected to disrupt normal transcription and translation of $APC$, either by interrupting the open reading frame, introducing premature stop codons, or abolishing proper splicing, yielding a non-functional allele.\n\nThus, the retroviral insertion in the wild-type $APC$ allele constitutes the “second hit” as per the Knudson two-hit hypothesis for tumor suppressor genes: the first hit is the pre-existing truncation in one allele, and the second hit is the insertional disruption of the other. The consequence is complete loss of $APC$ function, leading to constitutive Wnt pathway activation and the observed transformed phenotype.\n\nAlternative explanations are less consistent with the data:\n- Option A posits activation of a nearby proto-oncogene, but the consistent finding of integration within an $APC$ exon directly explains transformation via $APC$ inactivation rather than coincidental proximity activation.\n- Option B conflicts with the design of the virus (no oncogenes) and does not account for the site-specific association with $APC$ disruption.\n- Option D implies a dominant-negative effect from a truncated protein produced by the disrupted allele; however, the critical and sufficient mechanism here is biallelic loss-of-function of a tumor suppressor, not dominant-negative interference.\n- Option E invokes an inflammatory response, which is not a plausible cell-autonomous mechanism for stable transformation in this in vitro setting and does not explain the specific integration site in $APC$.\n\nTherefore, the most accurate molecular explanation is that retroviral integration into the wild-type $APC$ exon inactivated the only remaining functional copy, producing complete $APC$ loss and transformation.", "answer": "$$\\boxed{C}$$", "id": "2105299"}, {"introduction": "Once a virus initiates a cell's transformation into a cancerous state, is the virus's job done, or is its presence continually required? This question distinguishes between a 'hit-and-run' mechanism and a state of 'oncogene addiction,' a concept with profound implications for cancer therapy. This practice puts you in the role of a researcher, challenging you to interpret an experiment designed to determine if a cancer cell is 'addicted' to a viral oncoprotein for its survival [@problem_id:2105324].", "problem": "A virologist is studying a newly discovered DNA virus, designated \"Novavirus,\" for its oncogenic potential. They have successfully created a stable fibroblast cell line, NV-F-C1, which is transformed by the virus. These cells have lost contact inhibition and grow in multilayered clusters known as foci. The transformation is mediated by a single viral protein, Onco-N.\n\nTo investigate the mechanism of transformation, the virologist engineers a special strain of Novavirus that expresses a temperature-sensitive (ts) version of the oncoprotein, called Onco-N-ts. This mutant protein is fully functional at a permissive temperature of 32.0 °C but denatures and becomes inactive at a non-permissive temperature of 39.0 °C.\n\nAn experiment is conducted where NV-F-C1 cells containing the Onco-N-ts gene are plated and cultured at the permissive temperature of 32.0 °C. After a week, a stable average number of foci has formed on the plates. At this point, half of the culture plates are shifted to the non-permissive temperature of 39.0 °C, while the other half (the control group) are maintained at 32.0 °C. Both sets are incubated for another 48 hours.\n\nThere are two prevailing hypotheses for the viral oncogenesis mechanism:\n1.  **Hit-and-Run**: The viral oncoprotein is only required to initiate transformation, causing permanent genetic or epigenetic changes. After this \"hit,\" the continued presence of the functional oncoprotein is not necessary to maintain the cancerous state.\n2.  **Oncogene Addiction**: The transformed cells are continuously dependent on the viral oncoprotein's activity to maintain their cancerous phenotype.\n\nFor the specific cell line and reversion conditions of this experiment, it is known that if the cells are experiencing oncogene addiction, the inactivation of the oncoprotein leads to the disappearance of 95% of the established foci within the 48-hour incubation period at the non-permissive temperature.\n\nIf the Novavirus operates via an oncogene addiction mechanism, calculate the expected ratio of the final average number of foci per plate at the non-permissive temperature to that at the permissive temperature. Express your answer as a decimal value.", "solution": "Define $N_{0}$ as the average number of established foci per plate at the moment of the temperature shift, after the initial week at the permissive temperature. By the problem statement, this number is stable at that time.\n\nFor the control plates maintained at the permissive temperature, the oncoprotein remains functional. Given the stability noted at the end of the first week, we take the final average number of foci after the additional $48$ hours to remain $N_{0}$:\n$$\nN_{\\text{perm}}=N_{0}.\n$$\n\nFor the plates shifted to the non-permissive temperature under the oncogene addiction mechanism, the inactivation of the oncoprotein for $48$ hours causes disappearance of $0.95$ of the established foci, so a fraction $1-0.95=0.05$ remains. Therefore, the final average number of foci on these plates is\n$$\nN_{\\text{non-perm}}=(1-0.95)N_{0}=0.05\\,N_{0}.\n$$\n\nThe requested ratio of the final average number of foci per plate at the non-permissive temperature to that at the permissive temperature is\n$$\nR=\\frac{N_{\\text{non-perm}}}{N_{\\text{perm}}}=\\frac{0.05\\,N_{0}}{N_{0}}=0.05.\n$$", "answer": "$$\\boxed{0.05}$$", "id": "2105324"}]}